Is Hexarelin legal in Delaware?
status · caveats apply
No FDA approval (Pharmacia development discontinued); WADA S2.2 explicitly named GH-releasing peptide. No state-level peptide restrictions beyond federal law in Delaware.
category: no approval · last verified May 13, 2026
§ 01
Quick answer
No FDA approval (Pharmacia development discontinued); WADA S2.2 explicitly named GH-releasing peptide. No state-level peptide restrictions beyond federal law in Delaware.
§ 02
Full status breakdown
Federal status
FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Unapproved; FDCA applies.
Personal possession: Not federally criminalized.
Delaware — state-specific
Sport-body status
WADA 2026
on prohibited list · class S2.2 · both
Explicitly named as 'examorelin (hexarelin)' under S2.2 (GH-releasing peptides).
USADA
banned
NCAA
banned
What we couldn’t verify
§ 03
Also known as
Hexarelin is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
ExamorelinHexarelinRPharmacia hexarelin
§ 04
Disclaimer
§ 05
Related
- Back to peptide legality lookup — pick a different compound or state
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch